Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Treace Medical Concepts, Inc. - Common Stock (NQ:TMCI)

5.460 +0.020 (+0.37%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Treace Medical Concepts, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Deadline Approaching: Treace Medical Concepts, Inc. (TMCI) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
From Law Offices of Howard G. Smith
Via Business Wire
TREACE MEDICAL CONCEPTS, INC. (NASDAQ: TMCI) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Treace Medical Concepts, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TMCI
From The Rosen Law Firm PA
Via GlobeNewswire
Law Offices of Frank R. Cruz Encourages Treace Medical Concepts, Inc. (TMCI) Investors To Inquire About Securities Fraud Class Action
From Law Offices of Frank R. Cruz
Via Business Wire
TMCI Stockholder Notice: Robbins LLP Reminds Shareholders of the Class Action Lawsuit Against Treace Medical Concepts, Inc.
From Robbins LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
From Pomerantz LLP
Via GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Treace Medical Concepts, Inc. (TMCI) Investors To Inquire About Securities Fraud Class Action
From Glancy Prongay & Murray LLP
Via Business Wire
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); NAPCO Security Technologies, Inc. (NASDAQ: NSSC); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NASDAQ: VIRT)
From Grabar Law Office
Via GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TMCI
From The Rosen Law Firm PA
Via GlobeNewswire
Law Offices of Howard G. Smith Encourages Treace Medical Concepts, Inc. (TMCI) Investors To Inquire About Securities Fraud Class Action
From Law Offices of Howard G. Smith
Via Business Wire
TREACE MEDICAL CONCEPTS, INC. (NASDAQ: TMCI) INVESTOR ALERT: Investors With Large Losses in Treace Medical Concepts, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire
TMCI Investors Have the Opportunity to Lead the Treace Medical Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
From Faruqi & Faruqi LLP
Via GlobeNewswire
Rosen Law Firm Urges Treace Medical Concepts, Inc. (NASDAQ: TMCI) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical
From Faruqi & Faruqi LLP
Via GlobeNewswire
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)
From Scott+Scott Attorneys at Law LLP
Via Business Wire
Treace Announces Upcoming Board Chair Transition
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference
Expands market-leading position with new best-in-class bunion technologies 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2024 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces First Surgical Cases Utilizing the SpeedAkin™ Anatomic Compression Implant
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2024 Revenue
From Treace Medical Concepts, Inc.
Via GlobeNewswire
The Law Offices of Frank R. Cruz Continues Its Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure
Positions Treace to Significantly Increase Share of Overall Bunion Market and Expand Surgeon Customer Base 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Invited To Contact The Schall Law Firm
Via ACCESSWIRE
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant
From Treace Medical Concepts, Inc.
Via GlobeNewswire
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud
Via ACCESSWIRE
Treace Medical Concepts Inc Is Being Investigated For Securities Law Violations And Investors With Losses Are Invited To Contact The Schall Law Firm
Via ACCESSWIRE
The Schall Law Firm Encourages Stockholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.